Evidence map›Paper›PMID 40792107›Full record

ArticleFrontiers in cellular and infection microbiology2025

Comparative evaluation of MALDI-ToF mass spectrometry and Sanger sequencing of the

Angel Sebastian Rodriguez-Pazmiño, Elsy Carvajal, Darwin Paredes-Núñez, Jose Echeverría, Joselyn Calderon, Solon Alberto Orlando, Henry Parra Vera, Miguel Angel Garcia-Bereguiain

Abstract readComparative StudyEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Angel Sebastian Rodriguez-PazmiñoOne Health Research Group, Universidad de Las Américas, Quito, Ecuador.
Elsy CarvajalOne Health Research Group, Universidad de Las Américas, Quito, Ecuador.
Darwin Paredes-NúñezOne Health Research Group, Universidad de Las Américas, Quito, Ecuador.
Jose EcheverríaInstituto Nacional de Salud Pública e Investigación, Guayaquil, Ecuador.
Joselyn CalderonInstituto Nacional de Salud Pública e Investigación, Guayaquil, Ecuador.
Solon Alberto OrlandoInstituto Nacional de Salud Pública e Investigación, Guayaquil, Ecuador.
Henry Parra VeraCentro de Investigación Microbiológica, Guayaquil, Ecuador.
Miguel Angel Garcia-BereguiainOne Health Research Group, Universidad de Las Américas, Quito, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non tuberculous mycobacteria (NTM) infections are increasing globally, underscoring the critical importance of accurate species-level identification for effective clinical management. This study aimed to evaluate the use of three conserved markers in the mycobacterial family (

Indexed as

Bacterial ProteinsChaperonin 60DNA-Directed RNA PolymerasesMycobacterium Infections, NontuberculousNontuberculous MycobacteriaRNA, Ribosomal, 16SSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationDNA, BacterialHumansPhylogenySequence Analysis, DNABacterial ProteinsChaperonin 60DNA, BacterialDNA-Directed RNA Polymerasesheat-shock protein 65, MycobacteriumRNA polymerase beta subunitRNA, Ribosomal, 16Sclinical performanceEcuadorMALDI-ToF MSnon-tuberculous mycobacteriaSanger sequencing

Identifiers

PMID40792107
PMCPMC12336121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.